AMEDISYS INC's ticker is AMED and the CUSIP is 023436108. A total of 267 filers reported holding AMEDISYS INC in Q3 2018. The put-call ratio across all filers is 1.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,775,075 | -0.3% | 51,125 | -2.4% | 1.15% | +6.5% |
Q2 2023 | $4,789,170 | -57.0% | 52,375 | -65.4% | 1.08% | -58.1% |
Q1 2023 | $11,136,941 | +16.9% | 151,420 | +32.8% | 2.58% | +28.8% |
Q4 2022 | $9,526,902 | +15.7% | 114,040 | +34.0% | 2.00% | +15.7% |
Q3 2022 | $8,236,000 | +20.8% | 85,090 | +31.2% | 1.73% | +35.3% |
Q2 2022 | $6,818,000 | -53.7% | 64,855 | -62.4% | 1.28% | +30.9% |
Q2 2018 | $14,740,000 | +70.1% | 172,470 | +20.1% | 0.98% | -17.8% |
Q1 2018 | $8,668,000 | +15.6% | 143,650 | +1.0% | 1.19% | +17.0% |
Q4 2017 | $7,498,000 | +32.4% | 142,250 | +40.6% | 1.02% | +28.3% |
Q3 2017 | $5,663,000 | -7.3% | 101,195 | +4.1% | 0.79% | -17.9% |
Q2 2017 | $6,108,000 | -23.4% | 97,245 | -37.7% | 0.96% | -26.2% |
Q1 2017 | $7,971,000 | +59.0% | 156,015 | +32.7% | 1.31% | -15.2% |
Q4 2016 | $5,013,000 | – | 117,600 | – | 1.54% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Park West Asset Management LLC | 751,719 | $70,210,555 | 6.45% |
Crabel Capital Management, LLC | 83,093 | $7,761 | 6.24% |
ALPINE ASSOCIATES MANAGEMENT INC. | 1,033,497 | $96,528,620 | 5.06% |
Vazirani Asset Management LLC | 35,000 | $3,269,000 | 5.00% |
Ergoteles LLC | 33,863 | $3,162,804 | 4.64% |
Sand Grove Capital Management LLP | 282,850 | $26,418 | 3.29% |
GABELLI & Co INVESTMENT ADVISERS, INC. | 162,973 | $15,221,678 | 2.48% |
BARDIN HILL MANAGEMENT PARTNERS LP | 80,923 | $7,558 | 2.44% |
Melqart Asset Management (UK) Ltd | 350,328 | $32,720,635 | 2.34% |
Westchester Capital Management, LLC | 850,386 | $79,426,052 | 2.32% |